{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:59:19Z","timestamp":1783468759309,"version":"3.55.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:00:00Z","timestamp":1727827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"crossref","award":["2021R1A2C2012926"],"award-info":[{"award-number":["2021R1A2C2012926"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s10384-024-01125-8","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T06:02:02Z","timestamp":1727848922000},"page":"681-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Analysis of clinical features and outcomes in patients with ocular myasthenia gravis according to anti-acetylcholine receptor antibody-seropositivity"],"prefix":"10.1007","volume":"68","author":[{"given":"Byung Joo","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyosook","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Taek","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,2]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mus.20950","volume":"37","author":"D Grob","year":"2008","unstructured":"Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008;37:141\u20139.","journal-title":"Muscle Nerve"},{"key":"1125_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s13760-018-0943-7","volume":"118","author":"G Galassi","year":"2018","unstructured":"Galassi G, Mazzoli M, Ariatti A, Kaleci S, Valzania F, Nichelli PF. Antibody profile may predict outcome in ocular myasthenia gravis. Acta Neurol Belg. 2018;118:435\u201343.","journal-title":"Acta Neurol Belg"},{"key":"1125_CR3","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/mus.27103","volume":"63","author":"A Nagaishi","year":"2021","unstructured":"Nagaishi A, Narita T, Woodhall M, Jacobson L, Waters P, Irani SR, et al. Autoantibodies in Japanese patients with ocular myasthenia gravis. Muscle Nerve. 2021;63:262\u20137.","journal-title":"Muscle Nerve"},{"key":"1125_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/0022-510X(91)90067-H","volume":"102","author":"B Birmanns","year":"1991","unstructured":"Birmanns B, Brenner T, Abramsky O, Steiner I. Seronegative myasthenia gravis: clinical features, response to therapy and synthesis of acetylcholine receptor antibodies in vitro. J Neurol Sci. 1991;102:184\u20139.","journal-title":"J Neurol Sci"},{"key":"1125_CR5","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0960-8966(96)00009-0","volume":"6","author":"A Evoli","year":"1996","unstructured":"Evoli A, Batocchi AP, Lo Monaco M, Servidei S, Padua L, Majolini L, et al. Clinical heterogeneity of seronegative myasthenia gravis. Neuromuscul Disord. 1996;6:155\u201361.","journal-title":"Neuromuscul Disord"},{"key":"1125_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/WNO.0000000000000413","volume":"36","author":"EL Guterman","year":"2016","unstructured":"Guterman EL, Botelho JV, Horton JC. Diagnosis of Tensilon-negative ocular myasthenia Gravis by Daily Selfie. J Neuroophthalmol. 2016;36:292\u20133.","journal-title":"J Neuroophthalmol"},{"key":"1125_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.3109\/00207454.2010.539307","volume":"121","author":"ZF Mao","year":"2011","unstructured":"Mao ZF, Yang LX, Mo XA, Qin C, Lai YR, He NY, et al. Frequency of autoimmune diseases in myasthenia gravis: a systematic review. Int J Neurosci. 2011;121:121\u20139.","journal-title":"Int J Neurosci"},{"key":"1125_CR8","doi-asserted-by":"publisher","first-page":"e00537","DOI":"10.1002\/brb3.537","volume":"6","author":"J Kubiszewska","year":"2016","unstructured":"Kubiszewska J, Szyluk B, Szczudlik P, Bartoszewicz Z, Dutkiewicz M, Bielecki M, et al. Prevalence and impact of autoimmune thyroid disease on myasthenia gravis course. Brain Behav. 2016;6:e00537.","journal-title":"Brain Behav"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1034\/j.1600-0404.2002.01191.x","volume":"106","author":"D Ratanakorn","year":"2002","unstructured":"Ratanakorn D, Vejjajiva A. Long-term follow-up of myasthenia gravis patients with hyperthyroidism. Acta Neurol Scand. 2002;106:93\u20138.","journal-title":"Acta Neurol Scand"},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1136\/bmj.1.5437.762","volume":"1","author":"BM Sahay","year":"1965","unstructured":"Sahay BM, Blendis LM, Greene R. Relation between myasthenia gravis and thyroid disease. Br Med J. 1965;1:762\u20135.","journal-title":"Br Med J"},{"key":"1125_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1212\/WNL.31.6.771","volume":"31","author":"WR Kiessling","year":"1981","unstructured":"Kiessling WR, Pflughaupt KW, Ricker K, Haubitz I, Mertens HG. Thyroid function and circulating antithyroid antibodies in myasthenia gravis. Neurology. 1981;31:771\u20134.","journal-title":"Neurology"},{"key":"1125_CR12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1600-0404.2006.00649.x","volume":"114","author":"C Toth","year":"2006","unstructured":"Toth C, McDonald D, Oger J, Brownell K. Acetylcholine receptor antibodies in myasthenia gravis are associated with greater risk of diabetes and thyroid disease. Acta Neurol Scand. 2006;114:124\u201332.","journal-title":"Acta Neurol Scand"},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3389\/fendo.2017.00169","volume":"8","author":"A Lopomo","year":"2017","unstructured":"Lopomo A, Berrih-Aknin S. Autoimmune thyroiditis and Myasthenia Gravis. Front Endocrinol (Lausanne). 2017;8:169.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1125_CR14","doi-asserted-by":"publisher","first-page":"e101986","DOI":"10.1371\/journal.pone.0101986","volume":"9","author":"L Sun","year":"2014","unstructured":"Sun L, Meng Y, Xie Y, Zhang H, Zhang Z, Wang X, et al. CTLA4 variants and haplotype contribute genetic susceptibility to myasthenia gravis in northern Chinese population. PLoS ONE. 2014;9:e101986.","journal-title":"PLoS ONE"},{"key":"1125_CR15","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/mus.27118","volume":"63","author":"B Claytor","year":"2021","unstructured":"Claytor B, Li Y. Challenges in diagnosing coexisting ocular myasthenia gravis and thyroid eye disease. Muscle Nerve. 2021;63:631\u20139.","journal-title":"Muscle Nerve"},{"key":"1125_CR16","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1136\/bjo.77.12.822","volume":"77","author":"ME Vargas","year":"1993","unstructured":"Vargas ME, Warren FA, Kupersmith MJ. Exotropia as a sign of myasthenia gravis in dysthyroid ophthalmopathy. Br J Ophthalmol. 1993;77:822\u20133.","journal-title":"Br J Ophthalmol"},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.1016\/j.ophtha.2009.04.039","volume":"116","author":"KI Chatzistefanou","year":"2009","unstructured":"Chatzistefanou KI, Kouris T, Iliakis E, Piaditis G, Tagaris G, Katsikeris N, et al. The ice pack test in the differential diagnosis of myasthenic diplopia. Ophthalmology. 2009;116:2236\u201343.","journal-title":"Ophthalmology"},{"key":"1125_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.3389\/fendo.2018.00801","volume":"9","author":"R An","year":"2018","unstructured":"An R, Li Y, Yang B, Wang H, Xu Y. Rare co-occurrence of ocular myasthenia gravis and thyroid-Associated Orbitopathy (Ophthalmopathy) in an individual with hypothyroidism. Front Endocrinol (Lausanne). 2018;9:801.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1125_CR19","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1196\/annals.1405.012","volume":"1132","author":"A Evoli","year":"2008","unstructured":"Evoli A, Bianchi MR, Riso R, Minicuci GM, Batocchi AP, Servidei S, et al. Response to therapy in myasthenia gravis with anti-MuSK antibodies. Ann N Y Acad Sci. 2008;1132:76\u201383.","journal-title":"Ann N Y Acad Sci"},{"key":"1125_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/WNO.0000000000000814","volume":"40","author":"AG Hamedani","year":"2020","unstructured":"Hamedani AG, Pistilli M, Singhal S, Shindler KS, Avery RA, Tamhankar MA. Outcomes after Transcervical Thymectomy for Ocular Myasthenia gravis: a Retrospective Cohort Study with Inverse Probability Weighting. J Neuroophthalmol. 2020;40:8\u201314.","journal-title":"J Neuroophthalmol"},{"key":"1125_CR21","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1067\/mtc.2001.116191","volume":"122","author":"PF Roberts","year":"2001","unstructured":"Roberts PF, Venuta F, Rendina E, De Giacomo T, Coloni GF, Follette DM, et al. Thymectomy in the treatment of ocular myasthenia gravis. J Thorac Cardiovasc Surg. 2001;122:562\u20138.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1125_CR22","doi-asserted-by":"publisher","first-page":"422","DOI":"10.21037\/jtd.2020.01.17","volume":"12","author":"X Liu","year":"2020","unstructured":"Liu X, Zhou W, Hu J, Hu M, Gao W, Zhang S, Zeng W. Prognostic predictors of remission in ocular myasthenia after thymectomy. J Thorac Dis. 2020;12:422\u201330.","journal-title":"J Thorac Dis"},{"key":"1125_CR23","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jamaneurol.2015.1444","volume":"72","author":"CE Peeler","year":"2015","unstructured":"Peeler CE, De Lott LB, Nagia L, Lemos J, Eggenberger ER, Cornblath WT. Clinical utility of acetylcholine receptor antibody testing in Ocular Myasthenia Gravis. JAMA Neurol. 2015;72:1170\u20134.","journal-title":"JAMA Neurol"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01125-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-024-01125-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-024-01125-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T08:06:02Z","timestamp":1732867562000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-024-01125-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,2]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1007\/s10384-024-01125-8","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,2]]},"assertion":[{"value":"13 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"B. J. Lee, None; J. Park, None; H. Ahn, None; H. T. Lim, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}